Founded in 1968, Morgenthaler is one of the leading venture capital and buyout firms in the world. It serves the life science, health care, pharmaceutical and information technology industries. The company maintains operations in Colorado, Massachusetts, New Jersey, Ohio and California. It works in partnership with more than 250 companies. Morgenthaler s investment portfolio includes Bayhill Therapeutics, Crossbow Technology, Catalyst Biosciences, Galleon Pharmaceuticals, OncoMed Pharmaceuticals, and Princeton Lightwave. It maintains NexTag, which is a portfolio company that features comparison-shopping site for products, financial services and automobiles.